Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series : World's leading Event Organizer

Back

Amer Zeidan


Amer Zeidan

Yale University,USA

Biography

Amer Zeidan MBBS, MHS, is an Assistant Professor of Medicine (Hematology) at Yale University. Dr. Zeidan has completed a hematology/oncology fellowship and a clinical research fellowship in myelodysplastic syndromes at Johns Hopkins University where he also earned a Master of Health Science (MHS) degree in Clinical Investigation. Dr. Zeidan received his MBBS degree from the Faculty of Medicine, University of Jordan, Amman, Jordan before completing his internal medicine residency at Rochester General Hospital, Rochester, NY. Dr. Zeidan's clinical interest is in the management of hematologic malignancies. The focus of his clinical/translational research is the development of novel therapies for myelodysplastic syndromes, acute myeloid leukemia and other myeloid malignancies. Dr. Zeidan has been working on designing and conducting early phase clinical trials in refractory myeloid malignancies especially focusing on immunotherapeutic and epigenetic approaches. In addition, Dr. Zeidan also has an interest in effectiveness and outcomes research in myeloid malignancies. Dr Zeidan has authored more than 70 peer-reviewed publications including more than 25 original research papers and several book chapters. Dr Zeidan has also presented many abstracts in national and international hematology meetings and delivered invited presentations in several prestigious institutions in USA and Mexico.

Abstract

Abstract : The utility of risk models in predicting outcomes of patients (pts) with higher-risk myelodysplastic syndromes (HR-MDS) treated with hypomethylating agents (HMA)